HALO (HALOZYME THERAPEUTICS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 2 institutional investors hold HALO (HALOZYME THERAPEUTICS INC) with a combined value of $53.74M across 49,657,000 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $45.62M (0.01% of their portfolio). 2 funds increased their holdings.
Total Institutional Value
$53.74M
Total Shares Held
49,657,000
Institutional Holders
2
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $45.62M | 0.01% | +0.0% |
| 2 | Point72 Asset Management, L.P. | $8.12M | 0.01% | +50.0% |